SRP-9001-103 ENDEAVOR - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults, Children
Study Details
Full Title
An Open-Label, Systemic Gene Delivery Study Using Commercial Process Material to Evaluate the Safety of and Expression From SRP-9001 in Subjects with Duchenne Muscular Dystrophy (ENDEAVOR)
Principal Investigator
Natalie Katz, MD, PhD
Pediatric Neurologist
Protocol Number
IRB:
PRO00120134
NCT:
NCT04626674
Phase
Phase I/II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment